Therapeutic Asset Ratings
13,155 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nivolumab
Bladder Squamous Cell Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Nivolumab
Urinary Bladder Neoplasm
Ikena Oncology
P2
B
(60)
Nivolumab
Breast Neoplasm
Providence Health & Services
P2
B
(60)
Nivolumab
Cervical Carcinoma
Fred Hutchinson Cancer Center
P2
B
(60)
Nivolumab
Exocrine Pancreatic Carcinoma
Emory University
P2
B
(60)
Nivolumab
Gastroesophageal Cancer
Shanghai Henlius Biotech
P2
B
(60)
Nivolumab
Malignant Urinary System Neoplasm
Spanish Oncology Genito-Urinary Group
P2
B
(60)
Nivolumab
Intravascular Large B-Cell Lymphoma
National Cancer Institute (NCI)
P2
B
(60)
Nivolumab
Plasmacytoid Variant Infiltrating Bladder Urothelial Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Nivolumab
Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
National Cancer Institute (NCI)
P2
B
(60)
Nivolumab
Kaposi'S Sarcoma
Fred Hutchinson Cancer Center
P2
B
(60)
Nivolumab
Kidney Medullary Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Nivolumab
Lymphoma
National Cancer Institute (NCI)
P2
B
(60)
Nivolumab
Lymphoproliferative Syndrome
National Cancer Institute (NCI)
P2
B
(60)
Nivolumab
Uterine Corpus Cancer
M.D. Anderson Cancer Center
P2
B
(60)
Nivolumab
Uterine Cancer
National Cancer Institute (NCI)
P2
B
(60)
Nivolumab
Cutaneous Neuroendocrine Carcinoma
Fred Hutchinson Cancer Center
P2
B
(60)
Nivolumab
Mesothelioma
Orion Corporation, Orion Pharma
P2
B
(60)
Nivolumab
Peritoneal Mesothelioma
TCR2 Therapeutics
P2
B
(60)
Nivolumab
Penile Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Nivolumab
Lip And Oral Cavity Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Nivolumab
Ovarian Cancer
Regeneron Pharmaceuticals
P2
B
(60)
Nivolumab
Papillary Renal Cell Carcinoma
City of Hope Medical Center
P2
B
(60)
Nivolumab
Squamous Cell Carcinoma Of Penis
National Cancer Institute (NCI)
P2
B
(60)
Nivolumab
Peritoneum Cancer
Enlivex Therapeutics RDO Ltd.
P2
B
(60)
Showing 1976 to 2000 of 13,155 assets
Previous
Page 80 of 527
Next